A Multicenter, Scan-Rescan, Human and Machine Learning CMR Study to Test Generalizability and Precision in Imaging Biomarker Analysis.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
10 2019
Historique:
entrez: 25 9 2019
pubmed: 25 9 2019
medline: 9 6 2020
Statut: ppublish

Résumé

Automated analysis of cardiac structure and function using machine learning (ML) has great potential, but is currently hindered by poor generalizability. Comparison is traditionally against clinicians as a reference, ignoring inherent human inter- and intraobserver error, and ensuring that ML cannot demonstrate superiority. Measuring precision (scan:rescan reproducibility) addresses this. We compared precision of ML and humans using a multicenter, multi-disease, scan:rescan cardiovascular magnetic resonance data set. One hundred ten patients (5 disease categories, 5 institutions, 2 scanner manufacturers, and 2 field strengths) underwent scan:rescan cardiovascular magnetic resonance (96% within one week). After identification of the most precise human technique, left ventricular chamber volumes, mass, and ejection fraction were measured by an expert, a trained junior clinician, and a fully automated convolutional neural network trained on 599 independent multicenter disease cases. Scan:rescan coefficient of variation and 1000 bootstrapped 95% CIs were calculated and compared using mixed linear effects models. Clinicians can be confident in detecting a 9% change in left ventricular ejection fraction, with greater than half of coefficient of variation attributable to intraobserver variation. Expert, trained junior, and automated scan:rescan precision were similar (for left ventricular ejection fraction, coefficient of variation 6.1 [5.2%-7.1%], Automated ML analysis is faster with similar precision to the most precise human techniques, even when challenged with real-world scan:rescan data. Assessment of multicenter, multi-vendor, multi-field strength scan:rescan data (available at www.thevolumesresource.com) permits a generalizable assessment of ML precision and may facilitate direct translation of ML to clinical practice.

Sections du résumé

BACKGROUND
Automated analysis of cardiac structure and function using machine learning (ML) has great potential, but is currently hindered by poor generalizability. Comparison is traditionally against clinicians as a reference, ignoring inherent human inter- and intraobserver error, and ensuring that ML cannot demonstrate superiority. Measuring precision (scan:rescan reproducibility) addresses this. We compared precision of ML and humans using a multicenter, multi-disease, scan:rescan cardiovascular magnetic resonance data set.
METHODS
One hundred ten patients (5 disease categories, 5 institutions, 2 scanner manufacturers, and 2 field strengths) underwent scan:rescan cardiovascular magnetic resonance (96% within one week). After identification of the most precise human technique, left ventricular chamber volumes, mass, and ejection fraction were measured by an expert, a trained junior clinician, and a fully automated convolutional neural network trained on 599 independent multicenter disease cases. Scan:rescan coefficient of variation and 1000 bootstrapped 95% CIs were calculated and compared using mixed linear effects models.
RESULTS
Clinicians can be confident in detecting a 9% change in left ventricular ejection fraction, with greater than half of coefficient of variation attributable to intraobserver variation. Expert, trained junior, and automated scan:rescan precision were similar (for left ventricular ejection fraction, coefficient of variation 6.1 [5.2%-7.1%],
CONCLUSIONS
Automated ML analysis is faster with similar precision to the most precise human techniques, even when challenged with real-world scan:rescan data. Assessment of multicenter, multi-vendor, multi-field strength scan:rescan data (available at www.thevolumesresource.com) permits a generalizable assessment of ML precision and may facilitate direct translation of ML to clinical practice.

Identifiants

pubmed: 31547689
doi: 10.1161/CIRCIMAGING.119.009214
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e009214

Subventions

Organisme : British Heart Foundation
ID : FS/10/40/28260
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/16/46/32187
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Auteurs

Anish Bhuva (AN)

Institute for Cardiovascular Science, University College London, United Kingdom
Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Wenjia Bai (W)

Institute for Cardiovascular Science, University College London, United Kingdom

Clement Lau (C)

Institute for Cardiovascular Science, University College London, United Kingdom

Rhodri Davies (RH)

Institute for Cardiovascular Science, University College London, United Kingdom
Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Yang Ye (Y)

Institute for Cardiovascular Science, University College London, United Kingdom
Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Heeraj Bulluck (H)

Institute for Cardiovascular Science, University College London, United Kingdom
Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Elisa McAlindon (E)

Institute for Cardiovascular Science, University College London, United Kingdom
Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Veronica Culotta (V)

Institute for Cardiovascular Science, University College London, United Kingdom

Peter Swoboda (PP)

Institute for Cardiovascular Science, University College London, United Kingdom
Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Gabriella Captur (G)

Institute for Cardiovascular Science, University College London, United Kingdom
Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Thomas Treibel (TA)

Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom
Imperial College London, South Kensington Campus, United Kingdom. William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, United Kingdom

Joao Augusto (JB)

Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Kristopher Knott (KD)

Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom
Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China

Andreas Seraphim (A)

Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

Graham Cole (GD)

Department of Cardiovascular Imaging, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom
Imperial College London, South Kensington Campus, United Kingdom. William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, United Kingdom

Steffen Petersen (SE)

Data Science Institute and Department of Medicine (W.B.), Department of Computing

Nicola Edwards (NC)

Data Science Institute and Department of Medicine

John Greenwood (JP)

Bristol Heart Institute, Bristol NIHR Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol, United Kingdom
Heart and Lung Centre, New Cross Hospital, Wolverhampton, United Kingdom

Chiara Bucciarelli-Ducci (C)

Bristol Heart Institute, Bristol NIHR Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol, United Kingdom

Alun Hughes (AD)

Multidisciplinary Cardiovascular Research Centre and Division of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom

Daniel Rueckert (D)

Multidisciplinary Cardiovascular Research Centre and Division of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom

James Moon (JC)

Imperial College London, National Heart and Lung Institute, Hammersmith Hospital, United Kingdom

Charlotte Manisty (CH)

Auckland City Hospital, New Zealand and Institute of Cardiovascular Science, University of Birmingham

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH